Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time

Thomas Hörtenhuber1, Birgit Rami-Mehar, Miriam Satler

  • 1Department of Pediatric and Adolescent Medicine, Medical University of Vienna and Vienna General Hospital, Vienna, Austria.

Diabetes Care
|January 24, 2013
PubMed

Insights

Endothelial progenitor cells (EPCs) are reduced in children with type 1 diabetes mellitus (T1DM). Improved glycemic control correlated with increased EPCs, suggesting a potential mechanism for reducing cardiovascular risk in T1DM patients.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Research
  • Cell Biology

Background:

  • Type 1 diabetes mellitus (T1DM) significantly elevates cardiovascular disease (CVD) risk in young adults.
  • Endothelial progenitor cells (EPCs) are crucial for vascular health and predict CVD outcomes in non-diabetic populations.

Purpose of the Study:

  • To investigate EPC levels in children with T1DM.
  • To determine the relationship between EPCs and T1DM characteristics, particularly glycemic control.

Main Methods:

  • An observational cohort study included 190 children (156 T1DM, 34 controls), matched for age and sex.
  • EPCs were quantified using flow cytometry at baseline and after 1 year.
  • Changes in EPCs and glycemic control (HbA1c) were analyzed longitudinally.

Main Results:

  • Children with T1DM exhibited significantly lower EPC counts compared to controls.
  • Glycated hemoglobin A1c (HbA1c) was the strongest independent predictor of reduced EPCs.
  • Improved glycemic control over 1 year was associated with a significant increase in EPC numbers, while worsening control led to a decrease.

Conclusions:

  • This prospective study is the first to show diminished EPCs in pediatric T1DM.
  • The findings suggest that improved glycemic control may enhance EPC function, potentially mitigating the elevated cardiovascular risk in children with T1DM.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...